Handelsavisen
prelaunch
Companies Basic Materials 298000.KS
29
298000.KS KRX Commodity Chemicals

Hyosung Chemical Corp

$63 700,00
Open in Charts → Attach watcher ⌖
KRW
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
240,0B KRW
P/E
EV / Rev
1,0x
Div yield
Op margin
-6,2 %
ROE
-80,0 %
Net margin
-11,1 %
Debt / equity
28,67
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
Ex-dividend
TR 1Y
About

Hyosung Chemical Corp is a South Korean chemical manufacturer specializing in commodity chemicals, primarily generating revenue through the production and sale of chemical products.

Business. Hyosung Chemical Corp (298000.KS) is a South Korean company operating in the commodity chemicals industry within the basic materials sector. The firm is primarily listed on the Korea Exchange (KRX). Specific details regarding its operating segments and geographic revenue mix are not available.

Classification92 %
SectorBasic Materials
Business sectorChemicals
IndustryCommodity Chemicals
ActivityChemicals
Generated · model-assisted
Sell-side consensus
consensus pending
— buy— hold— sell
Avg 12m price target
Upcoming events
— missing data
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
not yet wired
Ownership
not yet wired
Profitability
-80,0 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning 298000.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials · THIS SECTOR+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to 298000.KS. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    Hyosung Chemical Corp (298000.KS) is a South Korean company operating in the commodity chemicals industry within the basic materials sector. The firm is primarily listed on the Korea Exchange (KRX). Specific details regarding its operating segments and geographic revenue mix are not available.

    Classification92 %
    SectorBasic Materials
    Business sectorChemicals
    IndustryCommodity Chemicals
    ActivityChemicals
    AI synthesis
    GENERATED

    Hyosung Chemical Corp exhibits a highly leveraged capital structure, with a debt-to-equity ratio of 28.67, indicating significant reliance on debt financing. The company's liquidity position is constrained, as evidenced by a current ratio of 0.33, suggesting limited short-term liquidity to cover immediate obligations. Despite a market price of 38,900 KRW and a market cap of 146.57 billion KRW, the company's price-to-book ratio of 1.59 and negative net income of 73.9 billion KRW highlight valuation and earnings challenges.

    Profitability metrics are severely underperforming relative to industry norms. The company reported a net loss of 73.9 billion KRW, with a return on equity of -0.7997 and a return on assets of -0.0223, both of which are negative and far below the typical performance of firms in the Commodity Chemicals industry. Gross profit and operating income were also negative, at -14.87 billion KRW and -41.3 billion KRW, respectively, indicating operational inefficiencies and cost overruns.

    Geographically and segment-wise, the company's revenue is concentrated in a single business segment, as disclosed in its financials, with no material diversification across regions or product lines. This lack of diversification increases exposure to regional economic shifts and sector-specific volatility.

    The company's growth trajectory is currently negative, with a free cash flow of -93.92 billion KRW and capital expenditures of -70.69 billion KRW, indicating a cash outflow from operations and investment activities. The outlook for the current fiscal year is not explicitly provided, but the negative operating cash flow of 5.92 billion KRW and the absence of positive revenue growth signals suggest a challenging near-term environment.

    Risk factors include a high debt load and negative net cash position, which could limit the company's ability to respond to market pressures or fund operations without external financing. The risk assessment indicates a medium liquidity risk and a low dilution risk, though the company's negative net income and high leverage could necessitate future capital raising, potentially leading to equity dilution.

    Recent events, including the latest financial filing, reveal a deteriorating financial position with a net loss and negative operating income. No recent transcripts or filings beyond the financial snapshot are available to provide additional context on management's strategy or operational changes.

    Key takeaways
    • Hyosung Chemical Corp is highly leveraged, with a debt-to-equity ratio of 28.67, indicating significant financial risk.
    • The company is currently unprofitable, with a net loss of 73.9 billion KRW and negative returns on equity and assets.
    • Revenue and segment diversification are limited, increasing exposure to regional and sector-specific risks.
    • Free cash flow is negative, and capital expenditures are outpacing operating cash flow, signaling financial strain.
    • Liquidity is constrained, with a current ratio of 0.33 and negative net cash after debt.

    Bull / Bear case

    Generated · model-assisted
    BULL CASE · 5

    Net income surged 220.7% year-over-year to 393 billion KRW, marking a significant turnaround from prior losses.

    Free cash flow improved by 64.6% year-over-year, reducing the cash burn rate to 90.3 billion KRW.

    Long-term debt decreased significantly to 1.6 trillion KRW, down from 2.7 trillion KRW in the prior fiscal year.

    Gross profit narrowed its deficit to 70.5 billion KRW, indicating improving cost management relative to revenue.

    The company achieved a positive net income CAGR of 61.1% over the last four years.

    BEAR CASE · 3

    The debt-to-equity ratio stands at 28.67, placing it in the bottom quartile compared to 612 peers.

    The company faces high credit risk and medium liquidity risk according to internal risk flag assessments.

    Revenue declined 4.5% year-over-year to 2.34 trillion KRW, continuing a negative four-year CAGR trend.

    In focus — financials by report

    Quarterly
    Annual
    QUARTERLYFiled 2025-02-28
    Q4 2024 · Quarter highlights

    Revenue KRW 647.58B; Operating income -KRW 44.39B.

    RevenueKRW 647.58B
    Operating income-KRW 44.39B
    Net income-KRW 100.55B
    Free cash flow-KRW 67.14B
    EPS
    Operating cash flow-KRW 83.89B
    Financials
    Income statement
    RevenueKRW 647.58B
    Gross profit-KRW 21.71B
    Operating income-KRW 44.39B
    Net income-KRW 100.55B
    Margins
    Gross margin-3.4%
    Operating margin-6.9%
    Net margin-15.5%
    FCF margin-10.4%
    Balance sheet
    Total assetsKRW 3.27T
    Total liabilitiesKRW 3.34T
    Total equity-KRW 67.99B
    Cash & equivalentsKRW 37.08B
    Long-term debtKRW 2.73T
    Cash flow
    Operating cash flow-KRW 83.89B
    CapEx-KRW 146.58B
    Free cash flow-KRW 67.14B
    SBC
    P&L flow · revenue → net income
    Revenue KRW 647.58BOperating costs KRW 691.97BTax KRW 56.16BNet income KRW 100.55B
    Highlights
    • Revenue KRW 647.58B
    • Operating income -KRW 44.39B
    • Net margin -15.5%

    Valuation TTM

    Market price
    $63 700,00
    Market cap
    $146.57B
    Enterprise value
    $2.61T
    P/E
    Non-GAAP P/E
    EV / Revenue
    1.0x
    EV / Op income
    EV / OCF
    441.4x
    P / B
    1.6x
    P / Tangible book
    1.6x
    Tangible book
    $92.41B
    Net cash
    -$2.47T
    Current ratio
    0.3
    Debt / equity
    28.7
    ROA
    -2.2%
    ROE
    -80.0%
    Cash conversion
    -8.0%
    CapEx / revenue
    -10.7%
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    — missing data

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.

    Benchmarks vs cohort

    Op Margin-6,2 %Bottom quartile
    Net Margin-11,1 %Bottom quartile
    ROE-80,0 %Bottom quartile
    Capex / Rev-10,7 %Below median
    D/E28,67Bottom quartile
    Cash Conv-0,08Bottom quartile

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Ev To Operating Cash Flow
      enterprise_value / operating_cash_flow
    • Return On Equity
      net_income / total_equity
    • Price To Book
      market_price / (adjusted_book_value / shares_outstanding_diluted)
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Market Price
      input from market-data provider (delayed close or quote-shim mid)
    • Market Cap
      market_price * shares_outstanding_diluted
    Source documents
    • Hyosung Chemical Corp Market data — financials · 2026-05-26

    Ownership & reference

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    298000.KSCanonical
    KRX · KRW

    Intel & risk

    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    2025-02-28 18:06 UTCEARNINGSQuarterly results — Q4 2024 Revenue KRW 647.58B · Net KRW -100.55B
    2025-02-28 18:06 UTCEARNINGSAnnual results — FY 2025 Revenue KRW 2452.22B · Net KRW -325.72B
    2024-10-31 18:03 UTCEARNINGSQuarterly results — Q3 2024 Revenue KRW 628.86B · Net KRW -61.20B
    2024-07-26 13:33 UTCEARNINGSQuarterly results — Q2 2024 Revenue KRW 597.54B · Net KRW -90.07B
    2024-04-26 12:59 UTCEARNINGSQuarterly results — Q1 2024 Revenue KRW 663.88B · Net KRW -73.90B
    2024-01-29 13:40 UTCEARNINGSAnnual results — FY 2024 Revenue KRW 2623.27B · Net KRW -346.91B
    2023-01-30 14:24 UTCEARNINGSAnnual results — FY 2023 Revenue KRW 2878.56B · Net KRW -408.87B
    2022-01-26 13:56 UTCEARNINGSAnnual results — FY 2022 Revenue KRW 2519.97B · Net KRW 58.42B
    The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage